Dynavax Technologies
DVAX
#5495
Rank
โ‚ฌ1.09 B
Marketcap
9,35ย โ‚ฌ
Share price
-0.64%
Change (1 day)
-22.83%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -โ‚ฌ34.82 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are โ‚ฌ0.33 Billion. In 2024 the company made an earning of โ‚ฌ32.33 Million, an increase over its 2023 earnings that were of โ‚ฌ2.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ34.82 Million-207.67%
2024 โ‚ฌ32.33 M1475.31%
2023 โ‚ฌ2.05 M-99.2%
2022 โ‚ฌ0.25 B238.78%
2021 โ‚ฌ76.18 M-257.89%
2020 -โ‚ฌ48.26 Million-58.58%
2019 -โ‚ฌ0.12 Billion-9.32%
2018 -โ‚ฌ0.13 Billion60.44%
2017 -โ‚ฌ80.07 Million-15.8%
2016 -โ‚ฌ95.09 Million4.22%
2015 -โ‚ฌ91.24 Million16.54%
2014 -โ‚ฌ78.29 Million37.09%
2013 -โ‚ฌ57.11 Million
2010 -โ‚ฌ40.88 Million214.85%
2009 -โ‚ฌ12.99 Million-37.33%
2008 -โ‚ฌ20.72 Million-66.07%
2007 -โ‚ฌ61.07 Million16.92%
2006 -โ‚ฌ52.23 Million170.36%
2005 -โ‚ฌ19.32 Million33.39%
2004 -โ‚ฌ14.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
โ‚ฌ17.74 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.63 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.83 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.49 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.24 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚ฌ8.00 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ10.17 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.52 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ7.08 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA